Noxsano
Private Company
Funding information not available
Overview
Noxsano is a private, commercial-stage company focused on advanced wound care through its proprietary nitric oxide delivery platform. Its initial commercial products, Restore Wound Pads and Gels, are marketed directly to veterinary professionals, demonstrating significant efficacy in accelerating wound healing. The company was founded by seasoned scientists and healthcare professionals with backgrounds at major corporations like Procter & Gamble and is supported by a strong advisory board. Noxsano's technology holds promise for expanding into the larger human wound care market.
Technology Platform
Patented point-of-use nitric oxide (NO) delivery platform. The technology is activated by water or saline to generate and deliver therapeutic nitric oxide directly to the wound bed for up to one week, accelerating healing and preventing infection.
Opportunities
Risk Factors
Competitive Landscape
In veterinary care, Noxsano competes with traditional wound dressings and a growing number of advanced options. In the target human market, competition is intense, including large players like 3M, Smith & Nephew, ConvaTec, and Mölnlycke, offering advanced modalities like antimicrobial dressings, collagen scaffolds, and negative pressure wound therapy.